Kros JM - Search Results

1

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.

Brat DJ, Aldape K, Colman H, Figrarella-Branger D, Fuller GN, Giannini C, Holland EC, Jenkins RB, Kleinschmidt-DeMasters B, Komori T, Kros JM, Louis DN, McLean C, Perry A, Reifenberger G, Sarkar C, Stupp R, van den Bent MJ, von Deimling A, Weller M. Brat DJ, et al. Among authors: kros jm. Acta Neuropathol. 2020 Mar;139(3):603-608. doi: 10.1007/s00401-020-02127-9. Epub 2020 Jan 29. Acta Neuropathol. 2020. PMID: 31996992 Free PMC article. No abstract available.

2

Proliferation of gemistocytic cells and glial fibrillary acidic protein (GFAP)-positive oligodendroglial cells in gliomas: a MIB-1/GFAP double labeling study.

Kros JM, Schouten WC, Janssen PJ, van der Kwast TH. Kros JM, et al. Acta Neuropathol. 1996;91(1):99-103. doi: 10.1007/s004010050398. Acta Neuropathol. 1996. PMID: 8773153

3

Signet-ring cell oligodendroglioma--report of two cases and discussion of the differential diagnosis.

Kros JM, van den Brink WA, van Loon-van Luyt JJ, Stefanko SZ. Kros JM, et al. Acta Neuropathol. 1997 Jun;93(6):638-43. doi: 10.1007/s004010050663. Acta Neuropathol. 1997. PMID: 9194905

4

The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor.

Straathof CS, van den Bent MJ, Ma J, Schmitz PI, Kros JM, Stoter G, Vecht CJ, Schellens JH. Straathof CS, et al. Among authors: kros jm. J Neurooncol. 1998 Mar;37(1):1-8. doi: 10.1023/a:1005835212246. J Neurooncol. 1998. PMID: 9525832

5

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas.

van den Bent MJ, Schellens JH, Vecht CJ, Sillevis Smit PA, Loosveld OJ, Ma J, Tijssen CC, Jansen RL, Kros JM, Verweij J. van den Bent MJ, et al. Among authors: kros jm. Eur J Cancer. 1998 Sep;34(10):1570-4. doi: 10.1016/s0959-8049(98)00138-5. Eur J Cancer. 1998. PMID: 9893630 Clinical Trial.

6

Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.

Luider TM, Kros JM, Sillevis Smitt PA, van den Bent MJ, Vecht CJ. Luider TM, et al. Among authors: kros jm. Electrophoresis. 1999 Apr-May;20(4-5):1087-91. doi: 10.1002/(SICI)1522-2683(19990101)20:4/5<1087::AID-ELPS1087>3.0.CO;2-6. Electrophoresis. 1999. PMID: 10344289

7

Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.

Watanabe T, Nakamura M, Kros JM, Burkhard C, Yonekawa Y, Kleihues P, Ohgaki H. Watanabe T, et al. Among authors: kros jm. Acta Neuropathol. 2002 Mar;103(3):267-75. doi: 10.1007/s004010100464. Epub 2001 Nov 22. Acta Neuropathol. 2002. PMID: 11907807

8

Immunophenotype of pleomorphic xanthoastrocytoma.

Giannini C, Scheithauer BW, Lopes MB, Hirose T, Kros JM, VandenBerg SR. Giannini C, et al. Among authors: kros jm. Am J Surg Pathol. 2002 Apr;26(4):479-85. doi: 10.1097/00000478-200204000-00010. Am J Surg Pathol. 2002. PMID: 11914626

9

Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications.

Perry A, Scheithauer BW, Macaulay RJ, Raffel C, Roth KA, Kros JM. Perry A, et al. Among authors: kros jm. J Neuropathol Exp Neurol. 2002 Nov;61(11):947-55. doi: 10.1093/jnen/61.11.947. J Neuropathol Exp Neurol. 2002. PMID: 12430711

10

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

van den Bent MJ, Looijenga LH, Langenberg K, Dinjens W, Graveland W, Uytdewilligen L, Sillevis Smitt PA, Jenkins RB, Kros JM. van den Bent MJ, et al. Among authors: kros jm. Cancer. 2003 Mar 1;97(5):1276-84. doi: 10.1002/cncr.11187. Cancer. 2003. PMID: 12599236 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page